Inventor · disambiguated record
Sumit Chanda
Also filed as: CHANDA SUMIT · CHANDA SUMIT K · CHANDA SUMIT KUMAR
4 granted patents·10 pending applications·9 citations·filing 2002–2022
67Inventor score
Files withIRM LLC7SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST3MODEL MEDICINES INC1SANFORD BURNHAM MED RES INST1SCRIPPS RESEARCH INST1
Top patents by PatentIndex Score
14 records- 0185US10300074B2Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapySANFORD BURNHAM MED RES INST·Filed 2015·Granted May 28, 2019·4 cites·7 claims
- 0282US10864217B2Use of inhibitor of apoptosis protein (IAP) antagonists in HIV therapySANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2019·Granted Dec 15, 2020·2 cites·9 claims
- 0373US9238815B2Compositions and methods for inhibiting human host factors required for influenza virus replicationSHAW MEGAN·Filed 2010·Granted Jan 19, 2016·3 cites·5 claims
- 0451US2005048585A1Methods and compositions for modulating NF-AT transcription factorIRM LLC·Filed 2003·Application pending·0 cites
- 0550US2005123904A1Methods and compositions for modulating herpesviral replication and transcription activatorIRM LLC·Filed 2004·Application pending·0 cites
- 0649US2023295181A1Inhibitor of apoptosis (iap) protein antagonistsSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2021·Application pending·0 cites
- 0746US2023115837A1Inhibitor of apoptosis (iap) protein antagonistsSANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST·Filed 2020·Application pending·0 cites
- 0844US7344833B2Methods and compositions for modulating activator protein 1IRM LLC·Filed 2003·Granted Mar 18, 2008·0 cites·18 claims
- 0944US2004171035A1Methods and compositions for modulating P53 transcription factorIRM LLC·Filed 2003·Application pending·0 cites
- 1043US2007226813A1Methods of screening for antitumor agentsSCRIPPS RESEARCH INST·Filed 2007·Application pending·0 cites
- 1143US2005037390A1Methods and compositions for modulating erythropoietin expressionIRM LLC·Filed 2004·Application pending·0 cites
- 1241US2003170642A1Identification of cellular targets for biologically active moleculesIRM LLC·Filed 2002·Application pending·0 cites
- 1339US2024082228A1Sars-cov-2 therapeuticsMODEL MEDICINES INC·Filed 2022·Application pending·0 cites
- 1439US2009156523A1Methods and compositions for modulating foxo1 activity and insulin signalingIRM LLC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sumit Chanda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →